Greenleaf Trust decreased its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 5.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,029 shares of the company’s stock after selling 3,478 shares during the quarter. Greenleaf Trust’s holdings in Procter & Gamble were worth $8,576,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at about $26,000. Montgomery Financial Services LLC acquired a new stake in Procter & Gamble in the second quarter valued at $28,000. Paladin Partners LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $29,000. Evergreen Advisors LLC acquired a new stake in shares of Procter & Gamble in the first quarter valued at approximately $37,000. Finally, Toews Corp ADV purchased a new position in shares of Procter & Gamble during the second quarter worth approximately $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Insider Transactions at Procter & Gamble
In other news, insider Susan Whaley sold 2,369 shares of the business’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the sale, the insider directly owned 30,730 shares of the company’s stock, valued at $4,466,298.20. The trade was a 7.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Balaji Purushothaman sold 4,181 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $160.71, for a total transaction of $671,928.51. Following the completion of the transaction, the insider directly owned 11,296 shares in the company, valued at approximately $1,815,380.16. The trade was a 27.01% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 58,647 shares of company stock valued at $9,268,508. Insiders own 0.23% of the company’s stock.
Procter & Gamble Stock Down 0.1%
NYSE:PG opened at $161.42 on Monday. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The firm has a market capitalization of $374.14 billion, a price-to-earnings ratio of 24.31, a PEG ratio of 3.97 and a beta of 0.36. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The business’s fifty day moving average price is $149.99 and its 200 day moving average price is $148.94.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.99 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.
Analyst Ratings Changes
Several analysts recently commented on PG shares. Bank of America reduced their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Wells Fargo & Company raised their target price on Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a report on Friday, October 23rd. Morgan Stanley raised their price objective on Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research note on Friday, October 23rd. Finally, Citigroup raised their price objective on shares of Procter & Gamble from $180.00 to $187.00 and gave the stock a “buy” rating in a research note on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $170.57.
Get Our Latest Analysis on Procter & Gamble
About Procter & Gamble
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
